Three decades of β-lactamase inhibitors

SM Drawz, RA Bonomo - Clinical microbiology reviews, 2010 - Am Soc Microbiol
Since the introduction of penicillin, β-lactam antibiotics have been the antimicrobial agents
of choice. Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened …

Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options

CC Sheu, YT Chang, SY Lin, YH Chen… - Frontiers in …, 2019 - frontiersin.org
Carbapenems are considered as last-resort antibiotics for the treatment of infections caused
by multidrug-resistant Gram-negative bacteria. With the increasing use of carbapenems in …

The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae

AJ Mathers, G Peirano, JDD Pitout - Clinical microbiology reviews, 2015 - Am Soc Microbiol
Escherichia coli sequence type 131 (ST131) and Klebsiella pneumoniae ST258 emerged in
the 2000s as important human pathogens, have spread extensively throughout the world …

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions

LS Tzouvelekis, A Markogiannakis… - Clinical microbiology …, 2012 - Am Soc Microbiol
The spread of Enterobacteriaceae, primarily Klebsiella pneumoniae, producing KPC, VIM,
IMP, and NDM carbapenemases, is causing an unprecedented public health crisis …

Carbapenem resistance: overview of the problem and future perspectives

G Meletis - Therapeutic advances in infectious disease, 2016 - journals.sagepub.com
Carbapenem resistance, mainly among Gram-negative pathogens, is an ongoing public-
health problem of global dimensions. This type of antimicrobial resistance, especially when …

Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance

N Woodford, JF Turton… - FEMS microbiology …, 2011 - academic.oup.com
Multilocus sequence ty** reveals that many bacterial species have a clonal structure and
that some clones are widespread. This underlying phylogeny was not revealed by pulsed …

Klebsiella pneumoniae carbapenemase variants resistant to ceftazidime-avibactam: an evolutionary overview

CA Hobson, G Pierrat, O Tenaillon… - Antimicrobial agents …, 2022 - Am Soc Microbiol
First variants of the Klebsiella pneumoniae carbapenemase (KPC), KPC-2 and KPC-3, have
encountered a worldwide success, particularly in K. pneumoniae isolates. These beta …

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

M Tumbarello, EM Trecarichi… - Journal of …, 2015 - academic.oup.com
Abstract Objectives Infections caused by Klebsiella pneumoniae (Kp) carbapenemase
(KPC)-producing strains of Kp have become a significant threat in recent years. To assess …

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

EB Hirsch, VH Tam - Journal of Antimicrobial Chemotherapy, 2010 - academic.oup.com
Bacteria producing Klebsiella pneumoniae carbapenemases (KPCs) are rapidly emerging
as a cause of multidrug-resistant infections worldwide. Bacterial isolates harbouring these …

“Stormy waters ahead”: global emergence of carbapenemases

G Patel, RA Bonomo - Frontiers in microbiology, 2013 - frontiersin.org
Carbapenems, once considered the last line of defense against of serious infections with
Enterobacteriaceae, are threatened with extinction. The increasing isolation of carbapenem …